Utachiona hweHIV neIsentress (raltegravir)

Isentress (ratelgravir) inonzi integrase inhibitor -chirwere chetachiona chinoshandiswa mukurapwa kweHIV . Isentress ndiyo yekutanga integrase inhibitor inobvumidzwa neU.S. Food and Drug Administration (FDA).

Muna Gumiguru 2007, yaive nemvumo yekushandiswa kune vanhu vakuru avo vairwisa mamwe madhiragi anorapwa . Asi munaJuly 2009, uye gare gare munaDecember 2011, FDA yakawedzera kuratidza kwayo, ichibvumira kushandiswa kune vose vakuru vane HIV, pamwe nevana vane makore maviri kusvika ku18.

Isentress iri pakati pezvinodhaka izvo zvino zvinokurudzirwa semasarudzo ekutanga-mutsara ekurapa HIV muSouth America

Formulations

Isentress inowanikwa mune maitiro mana akasiyana:

Usambogadzirisa Isentress chewables kana muromo kumiswa kweIsentress film-coated mapiritsi sezvo maumbirwo acho asina bioquivalent. Shandisa chete sezvakarayirwa (ona Zvikamu zviri pasi).

Dosages

Isentress 400mg, mahwendefa akafukidzwa nefirimu inofanira kunyorerwa kuvanhu vakuru uye kuvana vakwegura vanogona kumedza mahwendefa, sezvinotevera:

Isentress chewable mahwendefa inofanira kurongerwa kune vana inorema makirogiramu makumi mana (20kg) kana kupfuura avo vasingakwanisi kumedza mahwendefa, sezvinotevera:

Isentress oral suspension kana chewable mahwendefa inofanira kurongerwa kune vana vanorema makirogiramu anenge 3kg kusvika pasi pemaundi 55 (25kg), sezvinotevera:

Drug Administration

Isentress inogona kutorwa kana pasina kudya. Isentress haikwanisi kutorwa payo uye inofanira kurongerwa sechikamu chekubatanidza antiretroviral therapy (kadhi) .

Nharaunda Dzakabatana

Zvinonyanya kuzivikanwa nemigumisiro yakaipa (inowanikwa mu2% kana pasi pezviitiko) ndeiyi:

Contraindications

Hapana

Zvinodhaka-Zvinodhaka Zvinodhaka

Ndapota vaudza chiremba wako kana iwe uri kutora chero ipi zvayo inotevera mishonga sezvo isingabvumirwi kubatanidzwa pamwe neIsentress uye inogona kupindira nehuwandu hwezvinodhaka:

Kufunga

Varwere vanoona zvirwere zvinotapira mushure mokutanga Isentress vanofanira kuonana nachiremba wavo pakarepo. Mishonga inofanira kumira uye kurapwa kwakatsvaga kana kukanganisa kunoperekedzwa nefivha, musuru kana hutano hunojoka, blisters kana maronda, kuchena kana kuvhara kwemaziso, kuvhara kwechiso kana muromo, kana zvinetso zvokufema. Varwere avo vakambotarisana ne hypersensitive reaction yeIsentress havafanirwi kuchinjwa zvakare nemishonga mushure mekugadzirisa zviratidzo.

Zvidzidzo zvezvipfuwo hazviratidzi mazai embryotic kana kuti fetal birth birth defects panguva yekuzvitakura mumakonzo kana marabvu akaratidzwa kuIsentress. Zvisinei, zvinokonzerwa neIsentress pamucheche nechecheche dzisina kunyanya kushandiswa, uye, semugumisiro, kunyamwa hazvikurudzirwi kuti vanaamai vatore Isentress.

Sources:

Dhipatimendi reHutano neHuman Services (DHHS). "Mirayiridzo yeKushandiswa kweAntiretroviral Agents muHIV-1-Vakabatwa Vakuru Nevana Vari Kuyaruka." Rockville, Maryland.

FDA. "FDA Inowedzera Kushandiswa kweHIV Drug Isentress kune Vana uye Vana Vachiri Kuyaruka." Silver Spring, Maryland; December 21, 2011.

Reuters. "UPDATE 2-FDA OKs Kuwedzerwa Kushandiswa kweMerck's Isentress HIV Mishonga." July 9, 2009.

US Food and Drug Administration (FDA). "Kurapa Zvinodhaka Mishonga - Zita reMishonga: Isentress (ratelgravir) 400mg Matetet." Silver Spring, Maryland; Gunyana 12, 2007.